Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.915 USD | +1.42% | +13.70% | +120.34% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+120.34% | 722M | |
+53.51% | 59.28B | |
+41.42% | 40.94B | |
-5.42% | 40.17B | |
-5.16% | 28.69B | |
+12.65% | 26.63B | |
-20.94% | 18.89B | |
+30.84% | 12.46B | |
+0.19% | 12.42B | |
+26.21% | 12.26B |
- Stock Market
- Equities
- TSHA Stock
- News Taysha Gene Therapies, Inc.
- Taysha to End TSHA-120 Program in Giant Axonal Neuropathy; Shares Down After-Hours